Paxlovid

nirmatrelvir, ritonavir

Approval

ApplicationNDA 217188
Approval dateMay 25, 2023
Approval year2023
SponsorPfizer

FDA-approved use

To treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Paxlovid: